392 related articles for article (PubMed ID: 15231678)
21. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.
Marchini S; Damia G; Broggini M; Pennella G; Ripamonti M; Marsiglio A; Geroni C
Cancer Res; 2001 Mar; 61(5):1991-5. PubMed ID: 11280757
[TBL] [Abstract][Full Text] [Related]
22. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Davis PD; Dougherty GJ; Blakey DC; Galbraith SM; Tozer GM; Holder AL; Naylor MA; Nolan J; Stratford MR; Chaplin DJ; Hill SA
Cancer Res; 2002 Dec; 62(24):7247-53. PubMed ID: 12499266
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
Kimura Y; Sumiyoshi M; Baba K
Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
[TBL] [Abstract][Full Text] [Related]
24. N-Phenyl-N'-(2-chloroethyl)ureas (CEUs) as potential antineoplastic agents. Part 3: role of carbonyl groups in the covalent binding to the colchicine-binding site.
Moreau E; Fortin S; Lacroix J; Patenaude A; Rousseau JL; C-Gaudreault R
Bioorg Med Chem; 2008 Feb; 16(3):1206-17. PubMed ID: 17998163
[TBL] [Abstract][Full Text] [Related]
25. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the antiangiogenic potential of AQ4N.
O'Rourke M; Ward C; Worthington J; McKenna J; Valentine A; Robson T; Hirst DG; McKeown SR
Clin Cancer Res; 2008 Mar; 14(5):1502-9. PubMed ID: 18316575
[TBL] [Abstract][Full Text] [Related]
27. Antimitotic antitumor agents: synthesis, structure-activity relationships, and biological characterization of N-aryl-N'-(2-chloroethyl)ureas as new selective alkylating agents.
Mounetou E; Legault J; Lacroix J; C-Gaudreault R
J Med Chem; 2001 Mar; 44(5):694-702. PubMed ID: 11262080
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of anti-microtubule biaryls and preliminary evaluation as vascular-disrupting agents.
Joncour A; Liu JM; Décor A; Thoret S; Wdzieczak-Bakala J; Bignon J; Baudoin O
ChemMedChem; 2008 Nov; 3(11):1731-9. PubMed ID: 18785200
[TBL] [Abstract][Full Text] [Related]
29. Intramolecular cyclization of N-phenyl N'(2-chloroethyl)ureas leads to active N-phenyl-4,5-dihydrooxazol-2-amines alkylating β-tubulin Glu198 and prohibitin Asp40.
Trzeciakiewicz A; Fortin S; Moreau E; C-Gaudreault R; Lacroix J; Chambon C; Communal Y; Chezal JM; Miot-Noirault E; Bouchon B; Degoul F
Biochem Pharmacol; 2011 May; 81(9):1116-23. PubMed ID: 21371445
[TBL] [Abstract][Full Text] [Related]
30. Allicin inhibits cell polarization, migration and division via its direct effect on microtubules.
Prager-Khoutorsky M; Goncharov I; Rabinkov A; Mirelman D; Geiger B; Bershadsky AD
Cell Motil Cytoskeleton; 2007 May; 64(5):321-37. PubMed ID: 17323373
[TBL] [Abstract][Full Text] [Related]
31. Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.
Watanabe J; Natsume T; Kobayashi M
Cancer Sci; 2006 Dec; 97(12):1410-6. PubMed ID: 16999818
[TBL] [Abstract][Full Text] [Related]
32. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of action of N-phenyl-N'-(2-chloroethyl)ureas in the colchicine-binding site at the interface between alpha- and beta-tubulin.
Fortin S; Wei L; Moreau E; Labrie P; Petitclerc E; Kotra LP; C-Gaudreault R
Bioorg Med Chem; 2009 May; 17(10):3690-7. PubMed ID: 19398206
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine.
Nishikawa T; Akiyama N; Kunimasa K; Oikawa T; Ishizuka M; Tsujimoto M; Natori S
Eur J Pharmacol; 2006 Jun; 539(3):151-7. PubMed ID: 16725138
[TBL] [Abstract][Full Text] [Related]
36. The microtubule depolymerizing agent CYT997 causes extensive ablation of tumor vasculature in vivo.
Burns CJ; Fantino E; Powell AK; Shnyder SD; Cooper PA; Nelson S; Christophi C; Malcontenti-Wilson C; Dubljevic V; Harte MF; Joffe M; Phillips ID; Segal D; Wilks AF; Smith GD
J Pharmacol Exp Ther; 2011 Dec; 339(3):799-806. PubMed ID: 21917561
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the hollow fiber assay for the determination of microtubule disruption in vivo.
Suggitt M; Swaine DJ; Pettit GR; Bibby MC
Clin Cancer Res; 2004 Oct; 10(19):6677-85. PubMed ID: 15475458
[TBL] [Abstract][Full Text] [Related]
38. Microtubule effects of welwistatin, a cyanobacterial indolinone that circumvents multiple drug resistance.
Zhang X; Smith CD
Mol Pharmacol; 1996 Feb; 49(2):288-94. PubMed ID: 8632761
[TBL] [Abstract][Full Text] [Related]
39. Thymosin {beta}(10) inhibits angiogenesis and tumor growth by interfering with Ras function.
Lee SH; Son MJ; Oh SH; Rho SB; Park K; Kim YJ; Park MS; Lee JH
Cancer Res; 2005 Jan; 65(1):137-48. PubMed ID: 15665289
[TBL] [Abstract][Full Text] [Related]
40. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
